Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas
- PMID: 19616915
- DOI: 10.1016/j.ejso.2009.06.010
Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas
Abstract
Aims: The aim of this study is to investigate the clinicopathologic risk factors associated with distant metastases (DMs) from head and neck squamous cell carcinomas (HNSCCs).
Methods: Between February 1990 and February 2000, a retrospective analysis of 391 HNSCC patients was performed. The frequency and the clinicopathologic risk factors for DM were evaluated by using univariate chi(2) tests and multiple stepwise logistic regression models. Statistical analysis of overall survival was performed by using Kaplan-Meier method.
Results: 44 patients (11.3%) developed DM in clinic. In a univariate analysis, clinical N stage, primary tumor site, level of tumor invasion, pathologic N stage and number of levels with pathologic lymph node were found to be significantly associated with the risk of DM. In a multivariate analysis, the most significant risk factors were number of levels with pathologic lymph node, level of tumor invasion, and primary tumor site. Kaplan-Meier analysis showed that overall survival rates of 44 patients with DMs in clinic were 56.8% at 1 year, 9.1% at 3 years, and 6.8% at 5 years, respectively.
Conclusions: The number of levels with pathologic lymph node, the site of primary tumor and the level of tumor invasion are decisive risk factors in determining the development of DM in head and neck SCC patients. Patients with multilevel nodal involvement in neck, with laryngeal and hypopharyngeal carcinomas, and patients with primary tumor invasion into muscular, bone or cartilage have the highest risk of developing DM.
Similar articles
-
[Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004 Mar;39(3):171-5. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004. PMID: 15283298 Chinese.
-
Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.J Oral Maxillofac Surg. 2010 Feb;68(2):268-75. doi: 10.1016/j.joms.2009.09.071. J Oral Maxillofac Surg. 2010. PMID: 20116694
-
Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.Laryngoscope. 2005 Sep;115(9):1561-7. doi: 10.1097/01.mlg.0000173202.56739.9f. Laryngoscope. 2005. PMID: 16148695
-
[Prognostic factors in squamous cell carcinoma of the head and neck].Gan To Kagaku Ryoho. 1996 Jun;23(7):949-56. Gan To Kagaku Ryoho. 1996. PMID: 8678550 Review. Japanese.
-
Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes.Head Neck. 2007 Jul;29(7):621-31. doi: 10.1002/hed.20576. Head Neck. 2007. PMID: 17230560 Review.
Cited by
-
The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors-A Multicenter Analysis of a Rare Event.Cancers (Basel). 2020 Jul 18;12(7):1950. doi: 10.3390/cancers12071950. Cancers (Basel). 2020. PMID: 32708389 Free PMC article.
-
The subclonal structure and genomic evolution of oral squamous cell carcinoma revealed by ultra-deep sequencing.Oncotarget. 2017 Mar 7;8(10):16571-16580. doi: 10.18632/oncotarget.15014. Oncotarget. 2017. PMID: 28157713 Free PMC article.
-
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1837-44. doi: 10.1016/j.ijrobp.2011.03.006. Epub 2011 May 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 21601373 Free PMC article.
-
Predictors for distant metastasis in head and neck cancer, with emphasis on age.Eur Arch Otorhinolaryngol. 2021 Jan;278(1):181-190. doi: 10.1007/s00405-020-06118-0. Epub 2020 Jun 15. Eur Arch Otorhinolaryngol. 2021. PMID: 32542417 Free PMC article.
-
Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program.Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2681-7. doi: 10.1007/s00405-015-3785-4. Epub 2015 Sep 22. Eur Arch Otorhinolaryngol. 2016. PMID: 26395117
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials